Drugs / DCreg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03726307 | Apr 2019 → May 2027 expected | disease related to solid organ transplantation | Angus W. Thomson PhD DSc | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCreg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03726307 ↗ |
| Known as | Regulatory Donor-Derived Dendritic Cells (DCreg) | “Regulatory Donor-Derived Dendritic Cells (DCreg)” NCT03726307 ↗ |
| Modality | Cell therapy | “donor-derived regulatory dendritic cell (DCreg) treatment” NCT03726307 ↗ |